Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

245.81 +1.10 (+0.45%)
Streaming Delayed Price Updated: 12:25 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
News headline image
Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes ↗
ResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss drugs could help diagnosis rates. 
Via Investor's Business Daily
News headline image
ResMed Analysts Boost Their Forecasts After Better-Than-Expected Earnings ↗
 
Via Benzinga
News headline image
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why NYSE:RMD qualifies as a good dividend investing stock. ↗
Why the dividend investor may take a look at RESMED INC (NYSE:RMD). 
Via Chartmill
News headline image
Expert Outlook: ResMed Through The Eyes Of 9 Analysts ↗
 
Via Benzinga
News headline image
Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet ↗
Tech earnings could come to the market’s rescue as traders remain jittery about the outcome of key inflation data due on Friday. 
Via Benzinga
Topics Economy
News headline image
RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024 ↗
RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
News headline image
Peering Into ResMed's Recent Short Interest ↗
 
Via Benzinga
News headline image
Why NYSE:RMD provides a good dividend, while having solid fundamentals. ↗
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
News headline image
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher ↗
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use. 
Via Investor's Business Daily
News headline image
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank ↗
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals. 
Via The Motley Fool
News headline image
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test ↗
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea. 
Via Investor's Business Daily
News headline image
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER). 
Via Benzinga
News headline image
Uncovering Dividend Opportunities with NYSE:RMD. ↗
Why RESMED INC (NYSE:RMD) provides a good dividend, while having solid fundamentals. 
Via Chartmill
News headline image
Cracking The Code: Understanding Analyst Reviews For ResMed ↗
 
Via Benzinga
News headline image
Why ResMed Stock Is Jumping Today ↗
The medical device maker beat expectations with its latest quarterly results. 
Via The Motley Fool
News headline image
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
From ResMed Inc.
Via GlobeNewswire
News headline image
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast ↗
Our Elliott Wave analysis updates the Australian Stock Exchange with Resmed Inc shares. We have identified an Expanded Flat correction pattern, indicating the potential for RMD to continue declining... 
Via Talk Markets
News headline image
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
From ResMed Inc.
Via GlobeNewswire
News headline image
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
From ResMed Inc.
Via GlobeNewswire
News headline image
Got $1,000? Buy These Hot Growth Stocks Before They Take Off ↗
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode. 
Via The Motley Fool
News headline image
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
From ResMed Inc.
Via GlobeNewswire
News headline image
MatrixCare Earns Three 2024 Best in KLAS Awards
MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent 
From MatrixCare
Via GlobeNewswire
News headline image
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years ↗
 
Via Benzinga
News headline image
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line ↗
ResMed reported better-than-expected sales and adjusted earnings. 
Via Investor's Business Daily
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.